Le Lézard
Classified in: Health
Subjects: TDS, FVT

Progress in Migraine Research, Promius Announces Presentations for the 70th American Academy of Neurology Annual Meeting


PRINCETON, N.J., April 21, 2018 /PRNewswire/ -- Promius Pharma LLC announces its presentations for the 70th American Academy of Neurology (AAN) Annual Meeting in Los Angeles, CA, April 21-27, 2018.

Promius will present 3 platform presentations, with one presentation selected for the "Best of" session, and 4 posters including data from the 2017 Migraine in America Symptoms and Treatment (MAST) Study, a longitudinal survey of more than 15,000 migraine patients.

"The latest results from the MAST Study are new milestones in characterizing migraine symptoms," said Richard B. Lipton, MD, Director of Montefiore Headache Center. "A better understanding of the migraine patient journey may help us optimize future treatment approaches."

"Best of" session platform presentation:

Other platform presentations include:

The 4 posters are:

"We are very excited to have such a robust representation of our scientific work at 70th AAN Annual Meeting" said Dr. Sagar Munjal, Vice President, Chief Medical Officer at Promius Pharma. "The MAST Study findings on the most bothersome symptoms is an excellent example of identifying key unmet needs in management of migraine. We are hopeful that DFN-02 will help address these unmet needs."

About the MAST Study

The MAST Study addresses gaps in knowledge due to changing demographics and treatment options in the US migraine community. MAST was designed to shed light on the current state of migraine symptom characteristics, including the most bothersome migraine symptoms and how pain interferes with daily functioning.

About Promius Pharma LLC

Promius Pharma is a wholly owned subsidiary of Dr. Reddy's Laboratories, one of the largest and most respected pharmaceutical companies in the world. With a robust commercial infrastructure and extensive research and development capabilities through its parent company, Promius Pharma is committed to bringing new products to market that meet patients' needs in dermatology and neurology. For more information, visit www.promiuspharma.com.

Contact information:
Promius Pharma, LLC
107 College Rd E
Princeton, NJ 08540 
www.promiuspharma.com

Investor Relations:
Ashish Girotra (USA)
[email protected]
+1 (609) 375-6145

Media Relations:
Lori McCreary (USA)
[email protected]
+1 (609) 375-2955

Copyright 2018 Promius Pharma, LLC

Disclaimer: This press release may include statements of future expectations and other forward-looking statements that are based on the management's current views and assumptions and involve known or unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. In addition to statements which are forward-looking by reason of context, the words "may", "will", "should", "expects", "plans", "intends", "anticipates", "believes", "estimates", "predicts", "potential", or "continue" and similar expressions identify forward-looking statements. Actual results, performance or events may differ materially from those in such statements due to without limitation, (i) general economic conditions such as performance of financial markets, credit defaults , currency exchange rates , interest rates , persistency levels and frequency / severity of insured loss events (ii) mortality and morbidity levels and trends, (iii) changing levels of competition and general competitive factors, (iv) changes in laws and regulations and in the policies of central banks and/or governments, (v) the impact of acquisitions or reorganisation , including related integration issues. The company assumes no obligation to update any information contained herein.

SOURCE Promius Pharma LLC


These press releases may also interest you

at 09:38
Atlanta's premier indoor multi-sports facility, Intown Stars Training and Events Center has been honored with several prestigious awards from the Georgia Business Journal's Best of Georgia and Atlanta Magazine's Best of Atlanta awards.   Through the...

at 09:35
ReAlta Life Sciences, Inc. ("ReAlta" or the "Company"), a mid-stage clinical biotech company dedicated to saving lives by rebalancing the inflammatory response to address life-threatening diseases, today announces that the company will be utilizing...

at 09:30
Athletico Physical Therapy has opened a new location in Grand Blanc, Michigan, located across from Kroger and next to Starbucks on S. Saginaw Rd. This location offers convenient hours, including early morning, late evening and Saturday appointments,...

at 09:27
Serum Detect, a cancer diagnostics company, is debuting a novel and promising approach for cancer early detection at the...

at 09:25
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the 2023 annual results as of 31 December 2023. Financial Highlights Revenue increased by 18.1% to...

at 09:22
A unique online platform, My Yoga Journey, has been launched by Yourself Yoga for Menopause to provide yoga exclusively for women in menopause who prefer a natural solution to help alleviate their symptoms....



News published on and distributed by: